Literature DB >> 7576970

Clinical strategies for the treatment of neuroblastoma.

D Niethammer1, R Handgretinger.   

Abstract

Neuroblastoma is the most common solid extracranial tumour in childhood. In spite of intensive efforts of clinicians and scientists the prognosis for advanced disease is still poor. This paper presents a short review of the state-of-the-art in conventional treatment including surgery, chemotherapy, and radiation. This is followed by a review of the treatment attempts with high dose chemotherapy followed by autologous bone marrow or stem cell transplantation. One of the main problems with this approach is the contaminating tumour cells. Finally the various immunotherapeutic strategies are summarised which are used to remove minimal residual disease. Later, our new approach, combining various treatment modalities, is described.

Entities:  

Mesh:

Year:  1995        PMID: 7576970     DOI: 10.1016/0959-8049(95)00032-e

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Targeted cytokines for cancer immunotherapy.

Authors:  H N Lode; R A Reisfeld
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.

Authors:  D Shabat; H N Lode; U Pertl; R A Reisfeld; C Rader; R A Lerner; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

3.  Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.

Authors:  H N Lode; R Xiang; S R Duncan; A N Theofilopoulos; S D Gillies; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Synthesis and characterization of new copper thiosemicarbazone complexes with an ONNS quadridentate system: cell growth inhibition, S-phase cell cycle arrest and proapoptotic activities on cisplatin-resistant neuroblastoma cells.

Authors:  Haiyuan Zhang; Ronald Thomas; David Oupicky; Fangyu Peng
Journal:  J Biol Inorg Chem       Date:  2007-10-02       Impact factor: 3.358

5.  Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

Authors:  Fabio Pastorino; Chiara Brignole; Monica Loi; Daniela Di Paolo; Annarita Di Fiore; Patrizia Perri; Gabriella Pagnan; Mirco Ponzoni
Journal:  Front Oncol       Date:  2013-08-05       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.